EVOTEC SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.625 EUR | +0.89% |
|
-1.18% | -54.77% |
| May. 06 | EVOTEC : Warburg Research reiterates its Buy rating | ZD |
| May. 03 | EVOTEC : RBC reiterates its Buy rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOTEC SE | Other Biotechnology & Medical Research | +0.89% | -1.18% | -54.77% | -41.02% | -57.51% | 1.82B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- EVT Stock
- Charts Evotec SE
- Comparison Chart